Drug Induced Acute Interatitital Nephritis #AIN #AKI #KidneyWk @ASNKidney In it’s pathogenesis allergic reaction mechanisms are involved #AIN #AKI #KidneyWk @ASNKidney

Different mechanisms related to Cyrstal Induced Kidney Damage
#CystalDamage #AKI #KidneyWk @ASNKidney Sulfadiazine, Acyclovir, Methothrexate, Ataxanavir clinical vignettes of #CystalDamage #AKI #KidneyWk @ASNKidney

#DrugToxicity a focus on mithocondrial damage. Consider different factors related to drug toxicity.
#KidneyWk @ASNKidney Proximal Convoluted Tubule involved in toxicity due to hi density of mitochondria #DrugToxicity #KidneyWk @ASNKidney

Plenary #3 at @ASNKidney #KidneyWk on Wearable Devices for Fluid Management: nanomaterials for #KidneyHealth - Silicon integrated circuits Devices mounted in the human body at different sites to monitor health status: different capabilities, minimally invasive (i.e. neonatal)
#WearableDevices #KidneyWk @ASNKidney

Mechanical Circulatory Support Devices and the Kidney beyond Cardiogenic Shock (high incidence of AKI) #CirculatoryDevices
#KidneyWk @ASNKidney Intravascular Devices: IAMP and Impella and their relationship with GFR and/or AKI
#CirculatoryDevices
#KidneyWk @ASNKidney

Focus on POCUS in CRS #FluidManagement
First of all understand what is POCUS and how to use it
#KidneyWk @ASNKidney Focused Clinical Questions in #AKI. Which are our regular tools and how they perform? @NephroP
#POCUS #KidneyWk @ASNKidney

A MUST: “mRNA as a medicine” Melissa Moore, MD leads us through drug development, from Penicillin to MABs #KidneyWk @ASNKidney More than 100 monoclonal antibodies have been approved by @US_FDA but they have multiple limitations #KidneyWk @ASNKidney

RRT in Septic AKI: is important to define objectives @DrRonWald #KidneyWk @ASNKidney AKIKI-2 Trial aim is to define the optimal initiation time
@DrRonWald #KidneyWk @ASNKidney